HealthcareServices

Stem Cell Therapy For Multiple Sclerosis Market Outlook 2026–2035: Growth Drivers and Industry Forecast

March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the stem cell therapy for multiple sclerosis market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Stem Cell Therapy For Multiple Sclerosis Market from 2026 to 2030?

The market size for stem cell therapy used in treating multiple sclerosis has experienced significant expansion over recent years. This market is projected to expand from $1.82 billion in 2025 to $2.05 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.4%. The historic expansion can be linked to several factors, including developments in multiple sclerosis treatment research, an increase in the diagnosis rates of autoimmune disorders, the broader implementation of stem cell clinical trials, more refined patient selection protocols, and the expanding presence of specialized neurology centers.

The stem cell therapy for multiple sclerosis market is anticipated to experience substantial growth in the upcoming years, with projections indicating it will reach $3.24 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.2%. This projected growth can be attributed to factors such as accumulating long-term efficacy data for stem cell therapies, an increasing demand for disease-modifying treatments, the expansion of personalized neurology care, rising investments in neuro-regenerative research, and enhanced collaboration between hospitals and research institutions. Prominent trends expected during this period include the increased adoption of autologous hematopoietic stem cell transplants, a growing focus on immune system reset therapies, the rising application of mesenchymal stem cells, more frequent use of targeted delivery methods, and improved clinical monitoring and outcome tracking.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30409&type=smp

What Drivers Are Affecting Demand In The Stem Cell Therapy For Multiple Sclerosis Market?

The increasing occurrence of multiple sclerosis (MS) is projected to contribute significantly to the expansion of the stem cell therapy for multiple sclerosis market going forward. Multiple sclerosis is a chronic autoimmune disorder affecting the central nervous system by damaging the protective myelin sheath surrounding nerve fibers, which impairs communication between the brain and body, causing symptoms such as fatigue, muscle weakness, and vision problems. The rising incidence of MS is largely attributed to improved diagnostic capabilities, as advancements in medical imaging and heightened awareness enable more accurate and earlier identification of cases, leading to higher reported numbers. Stem cell therapy for multiple sclerosis helps in repairing compromised myelin, modulating abnormal immune responses, and promoting nerve cell regeneration, thereby aiding in the reduction of symptoms and potentially slowing disease progression. For instance, in May 2024, according to a report published by the MS Trust, a UK-based organization, approximately 2.9 million people worldwide are affected by multiple sclerosis, including over 150,000 individuals living with the condition in the UK. Therefore, the increasing prevalence of multiple sclerosis is anticipated to drive the growth of the stem cell therapy for multiple sclerosis market.

Which Segments Are Gaining Traction In The Stem Cell Therapy For Multiple Sclerosis Market?

The stem cell therapy for multiple sclerosis market covered in this report is segmented –

1) By Type Of Stem Cell: Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells, Mesenchymal Stem Cells, Hematopoietic Stem Cells

2) By Treatment Approach: Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy

3) By Delivery Method: Intravenous Injection, Intrathecal Injection, Direct Intraspinal Administration

4) By Application: Relapsing-Remitting Multiple Sclerosis (RRMS), Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), Progressive Relapsing Multiple Sclerosis (PRMS)

5) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Embryonic Stem Cells: Inner Cell Mass Cells, Blastocyst Derived Cells, Totipotent Stem Cells

2) By Adult Stem Cells: Bone Marrow Stem Cells, Neural Stem Cells, Tissue Specific Stem Cells

3) By Induced Pluripotent Stem Cells: Reprogrammed Somatic Cells, Patient Derived Cells

4) By Mesenchymal Stem Cells: Adipose Derived Stem Cells, Umbilical Cord Derived Stem Cells, Bone Marrow Derived Stem Cells

5) By Hematopoietic Stem Cells: Peripheral Blood Stem Cells, Bone Marrow Stem Cells, Umbilical Cord Blood Stem Cells

What Industry Trends Are Transforming The Stem Cell Therapy For Multiple Sclerosis Market?

Leading companies in the stem cell therapy for multiple sclerosis market are concentrating on developing innovative products, such as adipose-derived mesenchymal stem cells, to improve the effectiveness, safety, and regenerative capacity of treatments for patients with relapsing-remitting and progressive forms of multiple sclerosis. Adipose-derived mesenchymal stem cells (ADMSCs) are multipotent stem cells sourced from adipose (fat) tissue, capable of differentiating into various cell types and displaying regenerative and immunomodulatory traits beneficial for treating autoimmune and neurodegenerative conditions like multiple sclerosis. For example, in August 2025, Hope Biosciences, LLC, a US-based biopharmaceutical firm, launched its HB-adMSCs therapy, which uses adipose-derived mesenchymal stem cells administered through high-dose infusions and repeat dosing over a 32-week period. This therapy integrates immunomodulatory and neuroregenerative mechanisms, holding the potential to decelerate disease progression and repair myelin damage, thereby distinguishing it from conventional immunosuppressive treatments.

Who Are The Top-Performing Companies In The Stem Cell Therapy For Multiple Sclerosis Market In Recent Years?

Major companies operating in the stem cell therapy for multiple sclerosis market are Sana Biotechnology Inc., Century Therapeutics Inc., Reelabs Private Limited, PlacidWay LLC, MedAccess Guarantee Ltd, Celltex Therapeutics Corporation, CELLTEX THERAPEUTICS CORP, BrainStorm Cell Therapeutics Ltd., Athersys Inc., Advancells Dermaceuticals Private Limited, ImStem Biotechnology Inc., NeuroGenesis Bio Inc., Stem Cell Medicine Ltd., Biotherapy International, R3 Stem Cell, Hope Biosciences LLC, FibroBiologics Inc., Global Institute of Stem Cell Therapy and Research Inc., ProgenCell, Stemwell

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/global-stem-cell-therapy-for-multiple-sclerosis-market-report

Which Region Currently Holds The Largest Share Of The Stem Cell Therapy For Multiple Sclerosis Market?

North America was the largest region in the stem cell therapy for multiple sclerosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell therapy for multiple sclerosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Stem Cell Therapy For Multiple Sclerosis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30409&type=smp

Browse Through More Reports Similar to the Global Stem Cell Therapy For Multiple Sclerosis Market 2026, By The Business Research Company

Autologous Stem Cell And Non Stem Cell Based Therapies Market Report 2026

https://www.thebusinessresearchcompany.com/report/autologous-stem-cell-and-non-stem-cell-based-therapies-global-market-report

Human Embryonic Stem Cells Market Report 2026

https://www.thebusinessresearchcompany.com/report/human-embryonic-stem-cells-global-market-report

Stem Cell Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cell-manufacturing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795